{"id":"b7904321-f32e-517f-bf7c-73a8805844ca","stable_key":"97957230-601f-5dec-8524-0812be8fadbf:l-threonine-yrdc-glioblastoma","predicate":"when_targeted_reduces","statement":"Targeting YRDC reduced t6A, translation and tumor growth in glioblastoma stem-cell cultures and in vivo tumor models.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"69d50911-0346-5d77-8878-2563e0260698","mechanism_event_label":"A tumor model depended on the machinery that uses threonine to modify tRNA.","subject":{"id":"3114b5d2-04d2-59d6-88c3-c04eb28aeeff","slug":"yrdc","display_name":"Human threonylcarbamoyladenylate synthase / YRDC","entity_type_key":"protein"},"object":{"id":"4cd02c59-4156-599b-b1e9-f48b6f80441a","slug":"human-gsc-t6a-translation","display_name":"Human glioblastoma stem-cell t6A and translation","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"69d50911-0346-5d77-8878-2563e0260698","stable_key":"97957230-601f-5dec-8524-0812be8fadbf:l-threonine-yrdc-glioblastoma-event","event_type":"observed_relationship","label":"A tumor model depended on the machinery that uses threonine to modify tRNA.","description":"Targeting YRDC reduced t6A, translation and tumor growth in glioblastoma stem-cell cultures and in vivo tumor models.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"3114b5d2-04d2-59d6-88c3-c04eb28aeeff","slug":"yrdc","display_name":"Human threonylcarbamoyladenylate synthase / YRDC","entity_type_key":"protein"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"4cd02c59-4156-599b-b1e9-f48b6f80441a","slug":"human-gsc-t6a-translation","display_name":"Human glioblastoma stem-cell t6A and translation","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"fcef4dc2-a7b6-5812-bc33-c8af3d83f4d0","slug":"l-threonine","display_name":"L-Threonine","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"5c27b149-da7e-5a90-8bd3-d4b2a42bb2ef","slug":"trna-threonylcarbamoyladenosine","display_name":"tRNA-bound N6-threonylcarbamoyladenosine / t6A37","entity_type_key":"rna"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_access","value_text":"Primary abstract","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"CRISPR screen, cultured glioblastoma stem cells and xenografts.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Genetic targeting of YRDC is distinct from nutritional restriction and from a demonstrated human cancer treatment.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"L-Threonine collection; species, compartment, exposure, co-substrates and manipulation remain explicit.","comparator":null,"unit":null,"notes":"","entity":{"slug":"l-threonine","display_name":"L-Threonine","entity_type_key":"small_molecule"}},{"dimension":"plain_language","value_text":"A tumor model depended on the machinery that uses threonine to modify tRNA.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Threonine fuels glioblastoma through YRDC-mediated codon-biased translational reprogramming. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38519786/ · DOI 10.1038/s43018-024-00748-7","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"8d52706d-04dd-5477-81fb-f78aad5d5b7b","evidence_kind":"source_excerpt","locator":"Lines 362-368","start_line":362,"end_line":368,"excerpt":"## l-threonine-yrdc-glioblastoma\nA tumor model depended on the machinery that uses threonine to modify tRNA.\nTargeting YRDC reduced t6A, translation and tumor growth in glioblastoma stem-cell cultures and in vivo tumor models.\nModel: CRISPR screen, cultured glioblastoma stem cells and xenografts.\nLimitations: Genetic targeting of YRDC is distinct from nutritional restriction and from a demonstrated human cancer treatment.\nEvidence access: Primary abstract\nThreonine fuels glioblastoma through YRDC-mediated codon-biased translational reprogramming. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38519786/ · DOI 10.1038/s43018-024-00748-7","model_system":"CRISPR screen, cultured glioblastoma stem cells and xenografts.","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Original curation paraphrase; evidence access and experimental limitations specified.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"35396730-235a-537e-8a05-c6ef2960c509","stable_key":"import-97957230-601f-5dec-8524-0812be8fadbf","title":"L-Threonine: translation, intestinal barrier, metabolism and cross-nutrient mechanisms (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text.","file_path":"","sha256":"3365aed939d9f567bd098449c7d67c7c00fb6c9ba163dcf34dc7cf6081f324fb","revision_id":"10a7b648-8dd7-5d4e-b618-c560a6e2d3c7","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}